BioRx Wins 10th Annual Fast 55 Award
Company ranks #1 among the fastest growing private companies in the Cincinnati region in the $100.1 million+ revenue category.
CINCINNATI, Ohio (June 18, 2014) – The Cincinnati Business Courier announced BioRx as the winner of its 2014 Fast 55 Award in the category of sales over $100 million. The annual Fast 55 Award, Greater Cincinnati's premier awards program, recognizes the region's fastest-growing private companies.
Nearly 600 people from the region assembled on June 5 for an awards ceremony at the Hyatt Regency in Cincinnati. Winners in five revenue categories were announced, including BioRx in the largest. To qualify, companies must be headquartered in the Cincinnati region and have average sales of at least $1 million over three consecutive years. Winners were recognized in each category for the fastest growth over that three-year period. With 2013 sales of $204 million, BioRx ranked first at 78%.
BioRx is a privately-owned specialty pharmacy based in Blue Ash, Ohio, co-founded by Philip Rielly and Eric Hill. “We are honored to be recognized with such a significant award,” said Rielly. “The Cincinnati region has a dynamic business environment, so we are very proud of our company and our people for what they’ve achieved.”
The company began operations in 2004 with only three employees, specializing in the home treatment of hemophilia. Now in its 10th year, BioRx serves well over 1,000 patients nationwide who live with a variety of rare diseases, including bleeding disorders, immune deficiencies, autoimmune disorders, hereditary angioedema, alpha-1 antitrypsin deficiency, and various nutrition and digestive disorders. Its rapid growth has seen the company expand to nearly 250 employees in 2014, up 30% from one year ago.
This new hiring has led the company to expand offices and relocate employees to three different sites in the Cincinnati area. In addition, the company recently announced the opening of its 7th regional pharmacy, located in Greensboro, North Carolina.
“Strategic investments in new markets and therapy areas will continue to drive our growth,” said Rielly. “That formula seems to work and we continue to enjoy the ride.”
Download news release (PDF)
Based in Cincinnati, Ohio, BioRx is one of the nation’s fastest growing providers of specialty pharmaceuticals and infusion services, delivering highly customized care for patients with certain rare and chronic diseases. BioRx offers pharmacy, nursing and education services to patients with hemophilia, primary immune deficiencies, autoimmune disorders, hereditary angioedema, alpha-1 antitrypsin deficiency, and nutrition and digestive disorders. The company’s clinical staff reaches patients and physicians in all 50 states. To learn more about BioRx and its products and services, visit www.biorx.com.